{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-046572","form_type":"8-K","ticker":"LTRN","cik":"0001763950","company_name":"Lantern Pharma Inc.","filed_at":"2023-12-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.354267+00:00","generated_at":"2026-06-07T05:58:33.088224+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Lantern Pharma raises CSO and CFO salaries and bonus targets effective Jan 1, 2024","bullets":["CSO Kishor Bhatia base salary increased to $316,000; target bonus set at 40% of base.","CFO David Margrave base salary increased to $413,800; target bonus set at 40% of base.","Changes effective January 1, 2024, based on independent compensation advisory firm analysis.","Amendments to employment agreements approved by Compensation Committee and Board."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-046572","json":"https://secwatch.observer/filing/0001493152-23-046572.json","markdown":"https://secwatch.observer/filing/0001493152-23-046572.md","text":"https://secwatch.observer/filing/0001493152-23-046572.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1763950/000149315223046572/0001493152-23-046572-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1763950/000149315223046572/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T05:58:33.088224+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}